Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Multicentric Open-label Phase III Clinical Trial to Evaluate the Efficacy of Continual Treatment Versus Discontinuation Based in the Presence of Prodromes in a First Episode of Non-affective Psychosis.

NCT01765829 is registered in ClinicalTrials.gov with Fundación Pública Andaluza Progreso y Salud as lead sponsor.

NCT NCT01765829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01765829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Multicentric Open-label Phase III Clinical Trial to Evaluate the Efficacy of Continual Treatment Versus Discontinuation Based in the Presence of Prodromes in a First Episode of Non-affective Psychosis.
Lead sponsor
Fundación Pública Andaluza Progreso y Salud
Phase
Phase 3
Overall status
Unknown status
Start date
November 30, 2012
Completion date
November 30, 2015
Enrollment
104 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

psychosis nos/other